$261.42
0.46%
Downside
Day's Volatility :1.61%
Upside
1.16%
51.31%
Downside
52 Weeks Volatility :52.56%
Upside
2.58%
Period | Ufp Technologies Inc | |
---|---|---|
3 Months | 35.39% | |
6 Months | 66.53% | |
1 Year | 74.77% | |
3 Years | 349.1% |
Market Capitalization | 2.0B |
Book Value | $38.46 |
Earnings Per Share (EPS) | 6.2 |
PE Ratio | 42.21 |
PEG Ratio | 0.0 |
Wall Street Target Price | 262.5 |
Profit Margin | 11.75% |
Operating Margin TTM | 15.4% |
Return On Assets TTM | 9.68% |
Return On Equity TTM | 17.68% |
Revenue TTM | 407.3M |
Revenue Per Share TTM | 53.32 |
Quarterly Revenue Growth YOY | 7.3999999999999995% |
Gross Profit TTM | 90.3M |
EBITDA | 73.4M |
Diluted Eps TTM | 6.2 |
Quarterly Earnings Growth YOY | 0.29 |
EPS Estimate Current Year | 6.63 |
EPS Estimate Next Year | 7.19 |
EPS Estimate Current Quarter | 1.1 |
EPS Estimate Next Quarter | 1.35 |
What analysts predicted
Upside of 0.41%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 190.5M | ↑ 28.82% |
Net Income | 14.3M | ↑ 55.39% |
Net Profit Margin | 7.51% | ↑ 1.28% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 198.4M | ↑ 4.16% |
Net Income | 19.8M | ↑ 38.01% |
Net Profit Margin | 9.96% | ↑ 2.45% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 179.4M | ↓ 9.58% |
Net Income | 13.4M | ↓ 32.31% |
Net Profit Margin | 7.45% | ↓ 2.51% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 206.3M | ↑ 15.02% |
Net Income | 15.9M | ↑ 18.83% |
Net Profit Margin | 7.7% | ↑ 0.25% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 353.8M | ↑ 71.48% |
Net Income | 41.8M | ↑ 163.06% |
Net Profit Margin | 11.81% | ↑ 4.11% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 400.1M | ↑ 13.08% |
Net Income | 44.9M | ↑ 7.5% |
Net Profit Margin | 11.23% | ↓ 0.58% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 91.2M | ↓ 5.91% |
Net Income | 8.5M | ↓ 56.69% |
Net Profit Margin | 9.27% | ↓ 10.88% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 97.8M | ↑ 7.14% |
Net Income | 9.7M | ↑ 15.09% |
Net Profit Margin | 9.96% | ↑ 0.69% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 100.0M | ↑ 2.34% |
Net Income | 11.9M | ↑ 22.01% |
Net Profit Margin | 11.88% | ↑ 1.92% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 100.8M | ↑ 0.75% |
Net Income | 11.7M | ↓ 1.59% |
Net Profit Margin | 11.6% | ↓ 0.28% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 101.5M | ↑ 0.71% |
Net Income | 11.6M | ↓ 0.74% |
Net Profit Margin | 11.44% | ↓ 0.16% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 105.0M | ↑ 3.46% |
Net Income | 12.7M | ↑ 9.35% |
Net Profit Margin | 12.09% | ↑ 0.65% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 189.6M | ↑ 37.18% |
Total Liabilities | 49.1M | ↑ 239.02% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 188.8M | ↓ 0.44% |
Total Liabilities | 26.8M | ↓ 45.53% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 203.2M | ↑ 7.65% |
Total Liabilities | 26.3M | ↓ 1.7% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 334.1M | ↑ 64.43% |
Total Liabilities | 139.7M | ↑ 430.9% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 377.5M | ↑ 12.99% |
Total Liabilities | 140.0M | ↑ 0.22% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 404.1M | ↑ 7.04% |
Total Liabilities | 118.0M | ↓ 15.68% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 377.5M | ↓ 3.67% |
Total Liabilities | 140.0M | ↓ 15.54% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 390.8M | ↑ 3.51% |
Total Liabilities | 144.3M | ↑ 3.07% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 398.0M | ↑ 1.85% |
Total Liabilities | 137.7M | ↓ 4.57% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 399.8M | ↑ 0.46% |
Total Liabilities | 127.4M | ↓ 7.47% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 404.1M | ↑ 1.08% |
Total Liabilities | 118.0M | ↓ 7.36% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 407.7M | ↑ 0.88% |
Total Liabilities | 112.7M | ↓ 4.56% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 21.3M | ↑ 22.04% |
Investing Cash Flow | -82.3M | ↑ 693.53% |
Financing Cash Flow | 26.3M | ↓ 5630.32% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 31.2M | ↑ 46.48% |
Investing Cash Flow | -5.8M | ↓ 92.99% |
Financing Cash Flow | -25.0M | ↓ 194.98% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 25.0M | ↓ 19.83% |
Investing Cash Flow | -4.3M | ↓ 26.2% |
Financing Cash Flow | -285.0K | ↓ 98.86% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 14.3M | ↓ 42.91% |
Investing Cash Flow | -101.5M | ↑ 2281.11% |
Financing Cash Flow | 74.0M | ↓ 26082.11% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 17.7M | ↑ 24.14% |
Investing Cash Flow | 1.3M | ↓ 101.27% |
Financing Cash Flow | -25.9M | ↓ 134.97% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 17.9M | ↓ 16511.01% |
Investing Cash Flow | -3.0M | ↓ 108.87% |
Financing Cash Flow | -20.7M | ↓ 28.19% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.7M | ↓ 90.37% |
Investing Cash Flow | -2.2M | ↓ 26.55% |
Financing Cash Flow | 2.6M | ↓ 112.41% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 8.9M | ↑ 415.21% |
Investing Cash Flow | -2.8M | ↑ 27.24% |
Financing Cash Flow | -7.3M | ↓ 385.34% |
Sell
Neutral
Buy
Ufp Technologies Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Ufp Technologies Inc | 15.28% | 66.53% | 74.77% | 349.1% | 578.13% |
Stryker Corporation | -1.68% | 13.87% | 16.1% | 31.82% | 78.85% |
Boston Scientific Corp. | 9.29% | 36.18% | 38.46% | 78.45% | 97.9% |
Edwards Lifesciences Corp. | 0.12% | 33.63% | 1.69% | 0.35% | 52.69% |
Abbott Laboratories | -1.24% | 5.06% | -3.89% | -10.41% | 37.67% |
Medtronic Plc | 6.9% | 13.14% | -4.7% | -32.51% | -3.85% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Ufp Technologies Inc | 42.37 | 42.37 | 0.0 | 6.63 | 0.18 | 0.1 | NA | 38.46 |
Stryker Corporation | 37.02 | 37.02 | 2.92 | 11.96 | 0.19 | 0.07 | 0.01 | 50.33 |
Boston Scientific Corp. | 61.76 | 61.76 | 1.8 | 2.33 | 0.09 | 0.05 | NA | 13.56 |
Edwards Lifesciences Corp. | 37.27 | 37.27 | 5.19 | 2.76 | 0.21 | 0.12 | NA | 11.82 |
Abbott Laboratories | 32.4 | 32.4 | 5.99 | 4.63 | 0.15 | 0.06 | 0.02 | 22.31 |
Medtronic Plc | 26.76 | 26.76 | 1.52 | 5.2 | 0.08 | 0.04 | 0.03 | 38.95 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Ufp Technologies Inc | Buy | $2.0B | 578.13% | 42.37 | 11.75% |
Stryker Corporation | Buy | $123.6B | 78.85% | 37.02 | 16.03% |
Boston Scientific Corp. | Buy | $108.0B | 97.9% | 61.76 | 12.05% |
Edwards Lifesciences Corp. | Buy | $52.1B | 52.69% | 37.27 | 23.01% |
Abbott Laboratories | Buy | $182.3B | 37.67% | 32.4 | 13.96% |
Medtronic Plc | Buy | $111.9B | -3.85% | 26.76 | 13.0% |
BlackRock Inc
Neuberger Berman Group LLC
Vanguard Group Inc
Renaissance Technologies Corp
Wasatch Advisors LP
State Street Corporation
ufp technologies is a producer of innovative custom-engineered components, products, and specialty packaging. founded in 1963 and headquartered in newburyport, massachusetts, our company has pioneered a long list of processes and applications, has a large portfolio of active patents, and holds proprietary positions on many advanced materials from leading global suppliers. with a deep and accomplished engineering team, ufp technologies is a critical link in the value chain between raw material suppliers and oems. our team acts as an extension of customers' in-house research, engineering and manufacturing groups, working closely with them to solve their most complex product and packaging challenges. using foams, plastics, composites, and natural fiber materials, we design and manufacture a vast range of solutions primarily for six target markets including medical, automotive, aerospace & defense, electronics, consumer and industrial.
Organization | Ufp Technologies Inc |
Employees | 3093 |
CEO | Mr. R. Jeffrey Bailly |
Industry | Process Industries |
Masonite International Corp
$261.42
-0.1%
Trex Co. Inc.
$261.42
-0.1%
Amn Healthcare Services Inc.
$261.42
-0.1%
Enlight Renewable Energy Ltd.
$261.42
-0.1%
E.l.f. Beauty, Inc.
$261.42
-0.1%
Standex International Corp
$261.42
-0.1%
Ishares Msci Min Vol Global Etf
$261.42
-0.1%
Restoration Hardware Holdings, Inc.
$261.42
-0.1%
Cleanspark Inc
$261.42
-0.1%